新型溶血素在临床检验中的价值  

The Value of New Type Hemolysin in Clinic Examination

作　　者：张宪华[1] 

机构地区：[1]河南省安阳市第五人民医院检验科,河南安阳455000

出　　处：《中国现代医生》2008年第17期114-114,136,共2页China Modern Doctor

摘　　要：目的观察新型溶血素在临床检验中的价值。方法用新型溶血素(A法)和传统溶血素(B法)在同一条件下分别对同一血常规质控样本进行Hb、WBC、PLT测定,各30次。然后对所得结果进行t检验,以观察其准确性及重复性。结果A法和B法的Hb、WBC、PLT的结果分别为(130.1±8.30),CV=6.38%;(3.567±0.272),CV=7.57%;(190.5±10.080),CV=5.30%和(125.5±4.02),CV=3.20%;(3.593±0.180),CV=5.01%;(194.5±8.514),CV=4.38%。两组配对t检验为t=2.74,P<0.05;t=0.44,P>0.05;t=1.67,P>0.05。结论新型溶血素的重复性较传统的差,其检测的WBC、PLT与传统法无差异,而Hb则略有偏差,但可通过调整其因数来纠正。Objective To observe the value of the new type hemolysin in clinic examination. Methods A whole blood control sample was examined thirty times for those markers which contain：white blood cell（WBC）, hemoglobin（Hb）and platelet（PLT）in the same condition by the new type hemolysin（A method）and the traditional type hemolysin（B method）. Then given a statistics analysis for the results. Results There was a significant difference for Hb results in the two methods （ t = 2.74, P 〈 0.05 ）, and no significant differences for WBC results （ t = 0.44, P 〉 0.05 ）, PLT results（ t = 1.67, P 〉 0.05）. Conclusion The traditional type hemolysin is better than the new type hemolysin in repetition, but the new type hemolysin is more safety for operater and condition in clinic examination.

关 键 词：溶血素 新型 检验 价值 

分 类 号：R446.11[医药卫生—诊断学]